Generation of Human-Induced Pluripotent Stem Cells From Anterior Cruciate Ligament.

anterior cruciate ligament human induced pluripotent stem cells ligament differentiation reprogramming tissue engineering

Journal

Journal of orthopaedic research : official publication of the Orthopaedic Research Society
ISSN: 1554-527X
Titre abrégé: J Orthop Res
Pays: United States
ID NLM: 8404726

Informations de publication

Date de publication:
01 2020
Historique:
received: 16 04 2019
accepted: 04 10 2019
pubmed: 16 10 2019
medline: 14 2 2020
entrez: 16 10 2019
Statut: ppublish

Résumé

Human-induced pluripotent stem cells (hiPSCs) are reprogrammed somatic cells and are an excellent cell source for tissue engineering applications, disease modeling, and for understanding human development. HiPSC lines have now been generated from a diverse range of somatic cell types and have been reported to retain an epigenetic memory of their somatic origin. To date, the reprogramming of a true ligament has not been reported. The aim of this study is to generate iPSCs from human anterior cruciate ligament (ACL) cells. ACL cells from three above-knee amputation donors, with donor matched dermal fibroblasts (DFs) were tested for reprogramming using an existing DF reprogramming protocol. ACL cells were, however, more sensitive than donor matched DF to transforming growth factor-β (TGF-β); displaying marked contraction, increased proliferation and increased TNC and COMP expression in vitro, which hindered reprogramming to iPSCs. Modification of the protocol by scoring the cell monolayer or by removal of TGF-β during ACL reprogramming resulted in emerging colonies being easier to identify and extract, increasing reprogramming efficiency. Following 30 passages in culture, the generated ACL derived iPSCs displayed pluripotency markers, normal karyotype and can successfully differentiate to cells of the three embryonic germ layers. This study illustrates it is possible to generate hiPSCs from ligament and identifies optimized ligament reprogramming conditions. ACL derived iPSCs may provide a promising cell source for ligament and related tissue engineering applications. © 2019 The Authors. Journal of Orthopaedic Research® published by Wiley Periodicals, Inc. on behalf of Orthopaedic Research Society J Orthop Res 38:92-104, 2020.

Identifiants

pubmed: 31613026
doi: 10.1002/jor.24493
pmc: PMC6972590
doi:

Types de publication

Evaluation Study Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

92-104

Subventions

Organisme : Medical Research Council
ID : MR/S002553/1
Pays : United Kingdom
Organisme : FP7 Health
ID : 602300
Pays : International
Organisme : Arthritis Research UK
ID : 20414
Pays : United Kingdom
Organisme : FP7 Health
ID : FP7/2007-2013
Pays : International
Organisme : Versus Arthritis
ID : 20414
Pays : United Kingdom
Organisme : Versus Arthritis
ID : 20786
Pays : United Kingdom

Informations de copyright

© 2019 The Authors. Journal of Orthopaedic Research® published by Wiley Periodicals, Inc. on behalf of Orthopaedic Research Society.

Références

Hepatology. 2010 May;51(5):1810-9
pubmed: 20432258
Tissue Eng Part A. 2014 Oct;20(19-20):2604-13
pubmed: 24628376
Development. 2005 Mar;132(6):1273-82
pubmed: 15703277
Cell Stem Cell. 2009 Oct 2;5(4):353-7
pubmed: 19796614
Nat Biotechnol. 2008 Nov;26(11):1276-84
pubmed: 18931654
Cell Stem Cell. 2009 Nov 6;5(5):491-503
pubmed: 19818703
J Biol Chem. 2010 Sep 17;285(38):29270-8
pubmed: 20595386
Tissue Eng Part A. 2010 Oct;16(10):3119-37
pubmed: 20486794
Nat Methods. 2009 Nov;6(11):805-8
pubmed: 19838168
Stem Cells. 2012 May;30(5):997-1007
pubmed: 22378611
Arthritis Rheum. 2011 Oct;63(10):3010-21
pubmed: 21953087
Nature. 2010 Sep 16;467(7313):285-90
pubmed: 20644535
Nat Biotechnol. 2010 Aug;28(8):848-55
pubmed: 20644536
Dev Biol. 2008 Jan 1;313(1):107-17
pubmed: 18022151
J Periodontal Res. 2011 Aug;46(4):438-47
pubmed: 21443752
Cell Stem Cell. 2010 Jul 2;7(1):64-77
pubmed: 20621051
J Cell Sci. 2005 Oct 1;118(Pt 19):4495-509
pubmed: 16179608
PLoS Genet. 2011 May;7(5):e1002085
pubmed: 21637780
Nat Biotechnol. 2010 Nov;28(11):1187-94
pubmed: 20967028
Arthritis Res Ther. 2014 Feb 04;16(1):R41
pubmed: 24490617
Arthritis Rheum. 2009 Dec;60(12):3686-92
pubmed: 19950276
Cochrane Database Syst Rev. 2011 Sep 07;(9):CD005960
pubmed: 21901700
PLoS One. 2010 Feb 01;5(2):e8975
pubmed: 20126639
Nat Methods. 2011 May;8(5):424-9
pubmed: 21478862
Tissue Eng Part A. 2018 Mar;24(5-6):361-368
pubmed: 28548630
Cell Stem Cell. 2011 Jan 7;8(1):96-105
pubmed: 21211784
Stem Cells. 2009 Jun;27(6):1276-87
pubmed: 19489094
Eur Cell Mater. 2012 Jan 12;23:1-12
pubmed: 22241609
Nat Biotechnol. 2015 Jun;33(6):638-45
pubmed: 25961409
Nature. 2011 Mar 3;471(7336):68-73
pubmed: 21289626
J Biol Chem. 2010 Apr 9;285(15):11227-34
pubmed: 20139068
EMBO J. 2015 May 12;34(10):1296-308
pubmed: 25820261
Sci Rep. 2016 Mar 03;6:22484
pubmed: 26935433
Cell Stem Cell. 2011 Jul 8;9(1):17-23
pubmed: 21726830
Stem Cell Res Ther. 2015 Jun 19;6:122
pubmed: 26088261
J Am Soc Nephrol. 2011 Jul;22(7):1221-8
pubmed: 21636641
Cell. 2007 Nov 30;131(5):861-72
pubmed: 18035408
Stem Cells Transl Med. 2016 Aug;5(8):1106-16
pubmed: 27280798
Proc Natl Acad Sci U S A. 1988 Jul;85(13):4894-7
pubmed: 3164478
Science. 2007 Dec 21;318(5858):1917-20
pubmed: 18029452
Stem Cell Res Ther. 2017 Jun 5;8(1):128
pubmed: 28583200
Cell Stem Cell. 2010 Jul 2;7(1):15-9
pubmed: 20621044
Stem Cell Res. 2019 Aug;39:101497
pubmed: 31326745

Auteurs

Steven Woods (S)

Division of Cell Matrix Biology and Regenerative Medicine, School of Biological Sciences, University of Manchester, Michael Smith Building, Oxford Rd, Manchester, M13 9PT, United Kingdom.

Nicola Bates (N)

Division of Cell Matrix Biology and Regenerative Medicine, School of Biological Sciences, University of Manchester, Michael Smith Building, Oxford Rd, Manchester, M13 9PT, United Kingdom.

Sara L Dunn (SL)

Division of Cell-Matrix Biology and Regenerative Medicine, Wellcome Trust Centre for Cell-Matrix Research, Faculty of Biology, Medicine and Health, School of Biological Sciences, University of Manchester, Manchester, United Kingdom.

Ferdinand Serracino-Inglott (F)

Department of Vascular Surgery, Central Manchester NHS Foundation Trust, Manchester, United Kingdom.

Tim E Hardingham (TE)

Division of Cell-Matrix Biology and Regenerative Medicine, Wellcome Trust Centre for Cell-Matrix Research, Faculty of Biology, Medicine and Health, School of Biological Sciences, University of Manchester, Manchester, United Kingdom.

Susan J Kimber (SJ)

Division of Cell Matrix Biology and Regenerative Medicine, School of Biological Sciences, University of Manchester, Michael Smith Building, Oxford Rd, Manchester, M13 9PT, United Kingdom.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH